Immunotherapy for diabetic amyotrophy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunotherapy for Diabetic Amyotrophy." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431604/all/Immunotherapy_for_diabetic_amyotrophy.
Immunotherapy for diabetic amyotrophy. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431604/all/Immunotherapy_for_diabetic_amyotrophy. Accessed November 22, 2024.
Immunotherapy for diabetic amyotrophy. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431604/all/Immunotherapy_for_diabetic_amyotrophy
Immunotherapy for Diabetic Amyotrophy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431604/all/Immunotherapy_for_diabetic_amyotrophy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunotherapy for diabetic amyotrophy
ID - 431604
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431604/all/Immunotherapy_for_diabetic_amyotrophy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -